Beam Therapeutics (BEAM) EBT Margin Growth (1y) (2020 - 2026)
Powered by 
Analysis
Beam Therapeutics (BEAM) EBT Margin Growth (1y) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -153.00 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -571.00 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 553.00 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 4,709.00 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 1,076.00 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 1,911.00 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | -392.00 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 29,565.00 |
| 10 | Beam Therapeutics | 3.10 Bn | 3.10 Bn | - | -2.31 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2.31 Mn |
| Mar 31, 2026 | 115,810.00 |
| Dec 31, 2025 | 51,460.00 |
| Sep 30, 2025 | -48,492.00 |
| Jun 30, 2025 | -43,513.00 |
| Mar 31, 2025 | -21,943.00 |
| Dec 31, 2024 | -34,610.00 |
| Sep 30, 2024 | -11,859.00 |
| Jun 30, 2024 | -36,163.00 |
| Mar 31, 2024 | -87,787.00 |
| Dec 31, 2023 | 23,199.00 |
| Sep 30, 2023 | -4,198.00 |
| Jun 30, 2023 | 6,836.00 |
| Mar 31, 2023 | 52,885.00 |
| Dec 31, 2022 | -5,970.00 |
| Sep 30, 2022 | 316,829.00 |
| Jun 30, 2022 | 98.33 Mn |
| Mar 31, 2022 | 333.90 Mn |
| Dec 31, 2021 | 67.93 Mn |
| Sep 30, 2021 | 61.55 Mn |